ERBB2 and cancer: AXL, CA9, ENO2, HER1, HER2, HER3, PRGN, and PDGF-AA are protein biomarkers of cancer that are associated with the proliferation and angiogenesis of cancer, and are potential targets for anti-cancer therapy [58,59,60,61,62,63,64,65].